Piramal Pharma Limited has appointed Viral Gandhi as Chief Technology Officer and Senior Management Personnel, with effect from 1 October 2026. The move signals a deliberate push to strengthen the company’s technology-led growth trajectory as it steps up digital focus across its portfolio and operations.
Gandhi currently serves as President and Group Chief Information Officer of the Piramal Group, a role that has positioned him at the helm of tech strategy and digital reinvention across the organization. His track record spans transformative roles, including Chief Information Officer at Cox & Kings Group, and a long tenure with Tata Consultancy Services where he worked with several Fortune 100 clients on technology transformation journeys. He brings more than two decades of experience in building and sustaining innovative technology platforms that aim to boost business agility and stakeholder engagement.
Educationally, Gandhi has completed an Executive Leadership Program at Harvard Business School and a Strategy and Innovation Program at MIT, complemented by a Bachelor’s degree in Engineering from VJTI, Mumbai. He has been recognized for contributions to technology and innovation through various awards over the years, underscoring a career built around digital strategy, platform thinking, and organizational transformation.
The appointment aligns Piramal Pharma Limited’s ambition to accelerate technology-enabled growth and leverage digital platforms to enhance patient, partner, and consumer experiences. As Gandhi steps into the CTO role, the company anticipates a deeper integration of IT leadership with business strategy, reinforcing its commitment to innovation in a rapidly evolving healthcare landscape. Additional details are available on Piramal Pharma’s corporate site.